REQUEST A DEMO
Total
USD $0.00
Search more companies

Elikem Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Elikem Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Elikem Pharmaceuticals Private Limited is an unlisted company, incorporated on 17/08/1992. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24231GJ1992PTC018162 and registration number is 018162.

Legal Address
Elikem Pharmaceuticals Pvt. Ltd. Plot No : 816/1, At : Rakanpur, Tal : Kalol,
Gandhinagar; Gujarat; Postal Code: 382721

Contact Details: Purchase the Elikem Pharmaceuticals Private Limited report to view the information.

Website: https://elikempharma.com/

Basic Information
Outstanding Shares:
Purchase the Elikem Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Elikem Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
August 17, 1992
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Elikem Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
14.02%
Total operating revenue
14.15%
Operating profit (EBIT)
39.65%
EBITDA
19.94%
Net Profit (Loss) for the Period
41.95%
Total assets
13.76%
Total equity
25.24%
Operating Profit Margin (ROS)
0.21%
Net Profit Margin
0.17%
Return on Equity (ROE)
2.37%
Debt to Equity Ratio
-194.02%
Quick Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?